Skip to content

Ipratropium

Ipratropium is an inhaled antimuscarinic bronchodilator. Listed uses include Chronic Obstructive Pulmonary Disease.

Combivent

Chronic Obstructive Pulmonary Disease

50/20mcg

Ipratropium with salbutamol 50/20mcg as a pressurised inhalation, used in the management of chronic obstructive pulmonary disease. Two bronchodilators.

From$22.10/ inhalerView

Combimist L Inhaler

Chronic Obstructive Pulmonary Disease, Asthma

50/20mcg

Combimist L Inhaler pairs levosalbutamol with ipratropium as a pressurised inhalation for COPD and asthma. A beta2-agonist with an antimuscarinic.

From$22.95/ inhalerView

Key points

  • It is used mainly for COPD symptom control, not as the sole rescue plan for sudden severe breathing difficulty.
  • Eye exposure can trigger pain or blurred vision, especially with glaucoma.
  • Worsening wheeze immediately after use needs urgent care.

Listings are for comparison and general information; suitability and supply depend on clinician and pharmacy checks, monitoring and prescription requirements.

Important safety checks

Inhaler technique, glaucoma, urinary retention and other anticholinergics require review.

When to seek urgent care

Seek urgent help for severe breathlessness, blue lips, inability to speak normally, eye pain with halos or facial swelling.

Further reading